Skip to main content

Rein Therapeutics, Inc.

RNTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001420565

No open-market purchases or sales by Rein Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $42.3M in total; no superinvestor holds it.

13F holders, Q3 2021

Institutional positions in Rein Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
43
−4 vs. Q2 2021
Shares held
32.9M
−287.5K (−0.9%) vs. Q2 2021
Total value
$33.6M
−$7.93M (−19.1%) vs. Q2 2021
New holders
5
11 more added
Sold out
9
10 more reduced

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 43 institutions
Q1 2021: 52 institutionsQ2 2021: 47 institutionsQ3 2021: 43 institutionsQ4 2021: 43 institutionsQ1 2022: 42 institutionsQ2 2022: 37 institutionsQ3 2022: 33 institutionsQ4 2022: 19 institutionsQ1 2023: 19 institutionsQ2 2023: 17 institutionsQ3 2023: 16 institutionsQ4 2023: 20 institutionsQ1 2024: 23 institutionsQ2 2024: 29 institutionsQ3 2024: 32 institutionsQ4 2024: 31 institutionsQ1 2025: 39 institutionsQ2 2025: 36 institutionsQ3 2025: 40 institutionsQ4 2025: 48 institutionsQ1 2026: 46 institutionsQ2 2026: 59 institutions
Value heldQ3 2021: $33.6M
Q1 2021: $48.0MQ2 2021: $41.5MQ3 2021: $33.6MQ4 2021: $18.9MQ1 2022: $16.5MQ2 2022: $8.34MQ3 2022: $5.86MQ4 2022: $3.21MQ1 2023: $1.30MQ2 2023: $1.83MQ3 2023: $1.59MQ4 2023: $3.24MQ1 2024: $11.0MQ2 2024: $13.5MQ3 2024: $16.3MQ4 2024: $13.1MQ1 2025: $10.6MQ2 2025: $9.30MQ3 2025: $9.76MQ4 2025: $12.5MQ1 2026: $14.8MQ2 2026: $42.3M
Institutions holding RNTX and their total value by quarter
QuarterHoldersValue
Q2 202659$42.3M
Q1 202646$14.8M
Q4 202548$12.5M
Q3 202540$9.76M
Q2 202536$9.30M
Q1 202539$10.6M
Q4 202431$13.1M
Q3 202432$16.3M
Q2 202429$13.5M
Q1 202423$11.0M
Q4 202320$3.24M
Q3 202316$1.59M
Q2 202317$1.83M
Q1 202319$1.30M
Q4 202219$3.21M
Q3 202233$5.86M
Q2 202237$8.34M
Q1 202242$16.5M
Q4 202143$18.9M
Q3 202143$33.6M
Q2 202147$41.5M
Q1 202152$48.0M

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding Rein Therapeutics, Inc.; share changes are against Q2 2021.

Institutions holding RNTX in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Satter Management Co., L.P.16,609,449$16.9M11.60%00.0%Unchanged
BVF Inc5,265,555$5.37M0.21%00.0%Unchanged
Vanguard Group Inc3,444,971$3.51M0.00%+4,338+0.1%Added
Ikarian Capital, LLC2,763,583$2.82M0.65%−36,417−1.3%Reduced
Geode Capital Management, LLC822,946$839.0K0.00%+56,133+7.3%Added
Blair William & Co803,160$819.0K0.00%+115,116+16.7%Added
Renaissance Technologies LLC734,721$749.0K0.00%−296,407−28.7%Reduced
AJU IB Investment Co., Ltd.517,558$528.0K0.34%00.0%Unchanged
Boothbay Fund Management, LLC312,325$319.0K0.01%−80,690−20.5%Reduced
BlackRock Inc.194,529$198.0K0.00%−4,128−2.1%Reduced
Virtu Financial LLC180,933$185.0K0.02%+180,933New
Taconic Capital Advisors LP135,000$138.0K0.01%00.0%Unchanged
Northern Trust Corp127,883$130.0K0.00%00.0%Unchanged
Game Plan Financial Advisors, LLC127,000$130.0K0.08%+27,000+27.0%Added
Wade G W & Inc100,993$103.0K0.00%00.0%Unchanged
Keebeck Wealth Management, LLC76,000$78.0K0.02%−79,627−51.2%Reduced
Morgan Jess S & Co Inc75,000$76.0K0.05%00.0%Unchanged
State Street Corp71,200$73.0K0.00%00.0%Unchanged
Millennium Management LLC57,116$58.0K0.00%−4,719−7.6%Reduced
Envestnet Asset Management Inc54,176$55.0K0.00%+19,522+56.3%Added
Morgan Stanley48,452$50.0K0.00%+10,730+28.4%Added
JFS Wealth Advisors, LLC31,807$32.0K0.00%+31,807New
Personal Cfo Solutions, LLC30,500$31.0K0.01%−3,000−9.0%Reduced
Kestra Advisory Services, LLC30,000$31.0K0.00%00.0%Unchanged
ExodusPoint Capital Management, LP30,093$31.0K0.00%+6,993+30.3%Added
US Bancorp25,000$26.0K0.00%00.0%Unchanged
Barclays PLC25,279$26.0K0.00%+17,743+235.4%Added
Qube Research & Technologies Ltd25,279$26.0K0.00%+25,279New
PVG Asset Management Corp23,555$24.0K0.07%+8,550+57.0%Added
Two Sigma Securities, LLC22,852$23.0K0.00%+22,852New
Mercer Global Advisors Inc20,997$21.0K0.00%00.0%Unchanged
Meitav Dash Investments Ltd21,000$21.0K0.00%+10,000+90.9%Added
Lake Street Advisors Group, LLC18,500$19.0K0.00%00.0%Unchanged
HRT Financial LP19,290$19.0K0.00%+19,290New
Advisor Group Holdings, Inc.16,625$17.0K0.00%+6,291+60.9%Added
Bank of America Corp11,239$11.0K0.00%−495−4.2%Reduced
Kore Private Wealth LLC11,183$11.0K0.00%00.0%Unchanged
Commonwealth Equity Services, LLC11,000$11.0K0.00%00.0%Unchanged
Ridgecrest Wealth Partners, LLC10,000$10.0K0.01%00.0%Unchanged
UBS Group AG7,684$8.00K0.00%−4,011−34.3%Reduced
Allworth Financial LP500$1.00K0.00%00.0%Unchanged
Jacobi Capital Management LLC500$1.00K0.00%00.0%Unchanged
Wells Fargo & Company405$00.00%−48−10.6%Reduced
Two Sigma Advisers, LP0$00.00%−124,800−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−77,405−100.0%Sold out
Citadel Advisors LLC0$00.00%−30,223−100.0%Sold out
Charles Schwab Investment Management Inc0$00.00%−27,406−100.0%Sold out
Hollow Brook Wealth Management LLC0$00.00%−25,000−100.0%Sold out
Candriam Luxembourg S.C.A.0$00.00%−22,556−100.0%Sold out
Bank Julius Baer & Co. Ltd, Zurich0$00.00%−20,000−100.0%Sold out
Victory Capital Management Inc0$00.00%−10,391−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−2,715−100.0%Sold out